LFM
IDXX icon

LGT Fund Management’s Idexx Laboratories IDXX Stock Holding History

LGT Fund Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,870
Closed -$1.05M – 253
2026
Q1 		$1.05M Buy
1,870
+990
+113% +$635K 0.05% 195
2025
Q4 		$600K Buy
880
+370
+73% +$252K 0.05% 168
2025
Q3 		$316K Sell
510
-40
-7% -$24.3K 0.03% 208
2025
Q2 		$295K Sell
550
-40
-7% -$19.1K 0.03% 210
2025
Q1 		$248K Buy
+590
New +$256K 0.02% 220
2022
Q2 		– Sell
-500
Closed -$277K – 192
2022
Q1 		$277K Sell
500
-4,800
-91% -$2.52M 0.04% 171
2021
Q4 		$3.49M Buy
+5,300
New +$3.33M 1.01% 38

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

LGT Fund Management's IDXX Position: Q2 2026 in Review

LGT Fund Management sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 1,870 shares — an estimated $1.05M sold.

LGT Fund Management first reported a position in IDXX in Q4 2021 and held it in 7 quarters. The position peaked at $3.49M in Q4 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • LGT Fund Management reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • LGT Fund Management sold 1,870 Idexx Laboratories shares in Q2 2026, an estimated $1.05M.
  • LGT Fund Management first reported a position in Idexx Laboratories in Q4 2021 and held it in 7 quarters.
  • LGT Fund Management's Idexx Laboratories position peaked at $3.49M in Q4 2021.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on LGT Fund Management's 13F filing for Q2 2026, filed 10 Aug 2026.